- Home
- EXAS vs DOCS Comparison
EXAS vs DOCS Comparison
Compare EXAS & DOCS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- EXAS
- DOCS
- Stock Information
- Founded
- EXAS 1995
- DOCS 2010
- Country
- EXAS United States
- DOCS United States
- Employees
- EXAS N/A
- DOCS N/A
- Industry
- EXAS Medical Specialities
- DOCS Retail: Computer Software & Peripheral Equipment
- Sector
- EXAS Health Care
- DOCS Technology
- Exchange
- EXAS Nasdaq
- DOCS Nasdaq
- Market Cap
- EXAS 11.0B
- DOCS 12.3B
- IPO Year
- EXAS N/A
- DOCS 2021
- Fundamental
- Price
- EXAS $100.87
- DOCS $46.26
- Analyst Decision
- EXAS Strong Buy
- DOCS Buy
- Analyst Count
- EXAS 18
- DOCS 20
- Target Price
- EXAS $72.44
- DOCS $68.55
- AVG Volume (30 Days)
- EXAS 7.2M
- DOCS 2.1M
- Earning Date
- EXAS 11-03-2025
- DOCS 11-06-2025
- Dividend Yield
- EXAS N/A
- DOCS N/A
- EPS Growth
- EXAS N/A
- DOCS 42.88
- EPS
- EXAS N/A
- DOCS 1.25
- Revenue
- EXAS $3,082,033,000.00
- DOCS $621,329,000.00
- Revenue This Year
- EXAS $16.68
- DOCS $13.54
- Revenue Next Year
- EXAS $12.36
- DOCS $11.26
- P/E Ratio
- EXAS N/A
- DOCS $37.17
- Revenue Growth
- EXAS 14.47
- DOCS 20.21
- 52 Week Low
- EXAS $38.81
- DOCS $46.12
- 52 Week High
- EXAS $101.87
- DOCS $85.21
- Technical
- Relative Strength Index (RSI)
- EXAS 91.11
- DOCS 18.07
- Support Level
- EXAS $66.00
- DOCS $46.38
- Resistance Level
- EXAS $69.08
- DOCS $67.10
- Average True Range (ATR)
- EXAS 3.80
- DOCS 2.48
- MACD
- EXAS 2.49
- DOCS -1.08
- Stochastic Oscillator
- EXAS 97.30
- DOCS 0.74
About EXAS Exact Sciences Corporation
Exact Sciences, headquartered in Madison, Wisconsin, provides cancer screening and diagnostic test products in the United States and internationally. Exact's Cologuard screening test is a noninvasive stool-based DNA test for colorectal cancer. The company also competes in the precision oncology market with Oncotype DX, a suite of tissue-based genomic tests for estimating recurrence risk and likelihood of benefit from chemotherapy for breast and colon cancer, and OncoExTra, a liquid-based comprehensive genomic profiling test. It also has a pipeline of blood-based tests for molecular residual disease, colorectal cancer screening, and multicancer screening.
About DOCS Doximity Inc.
Doximity Inc is a digital platform for U.S. medical professionals. The cloud-based platform provides members with tools specifically built for medical professionals, enabling them to collaborate with their colleagues, securely coordinate patient care, conduct virtual patient visits, stay up-to-date with the latest medical news and research, and manage their careers and on-call schedules.